For early diagnosis of MI and monitoring of ACS
The Cardiac Array combines routine with novel early markers to give a clear picture of a patient’s cardiac status. It can be used in A&E settings as well as cardiac and medical wards to determine the diagnosis of MI, and assess the patient’s risk of future cardiac events.
A 3 year study with over 1000 patients confirmed the cardiac biochip to be 89% sensitive for MI diagnosis shortly after a cardiac event (3-6 hours), which constitutes a 20% increase in sensitivity against troponin alone. It also has the ability of ACS profiling and, with a negative predictive value of 98% at 3-6 hours, is a perfect rule out test for the emergency setting.
A full range of controls and calibrators are also available.